| [ORAL
SESSIONS] |
| 8:15 |
REGISTRATION |
 |
8:45-9:00
(15) |
OPENING
OPENING REMARKS |
Endo M
President, Hirosaki International Forum of Medical Science, Secretary
General, Organizing Committee, The 4th Meeting of Hirosaki International
Forum of Medical Science Dean, Hirosaki University School of Medicine
|
| WELCOME SPEECH |
Nakamura S
Vice-President, Hirosaki University
|
 |
| [SESSION
I] |
METABOLISM OF GLYCOLIPIDS
AND PATHOLOGY |
|
Chairpersons: Li SC
(Department of Biochemistry, Tulane University School of Medicine,
New Orleans, LA, USA),
Tsuchida S
(Department of Biochemistry, Hirosaki University School of Medicine,
Hirosaki, Japan) |
9:00-9:40
(40) |
I-1 CATABOLISM OF GM2 IN MAN AND MOUSE
|
Li YT, and Li SC
Department of Biochemistry, Tulane University School of Medici ne,
New Orleans, LA, USA
|
 |
9:40-10:20
(40) |
I-2 GLYCOSPHINGOLIPID BIOLOGY AND DESEASE
|
Proia RL
Genetics of Development and Disease Branch, National Institute
of Diabetes and Digestive and Kidney Diseases, National Institut
es of Health, Bethesda, MD, USA
|
 |
10:20-10:35
(15) |
I-3 MICROGLIAL ACTIVATION AND INFLAMMATORY
REACTION PRECEDING NEURODEGENERATION IN SANDHOFF DISEASE |
Wada R1,
2, Tifft CJ2, 3, and
Proia RL2
1Department of Pathology, Hirosaki
University School of Medicine, H irosaki, Japan 2Genetics
of Development and Disease Branch, National Institute of Diabetes
and Digestive and Kidney Diseases, National Institu tes of Health,
Bethesda, MD, USA, 3Department
of Medical Gen etics, Children's National Medical Center, Washington,
DC, USA
|
 |
10:35-11:00
(25) |
I-4 TISSUE SPECIFIC CONTROL OF GLYCO-CHAINS
|
Suzuki A1,
Omae F1, Enomoto A1,
Yoshioka S1, Sekine M2,
Kikkawa Y2, Taya C2,
Yonekawa H2, Takenaka M3,
Matsuoka Y3, Imai E 3,
Izawa M4, and Kannagi R4
1Sphingolipid Expression Laboratory,
RIKEN Frontier Research System, Tokorozawa, 2Department
of Laboratory Animal Science, Tokyo Metropolitan Institute of
Medical Science, Tokyo, 3The
First Department of Medicine, Osaka University School of Medicine,
Osaka, and 4Program of Experimental
Pathology, Aichi Cancer Center, Aichi, Japan
|
 |
| 11:00-11:20
(20) |
COFFEE
BREAK AND DISCUSSION OF POSTERS |
 |
| [SESSION
II] |
ROLES OF N-GLYCANS
IN TISSUES |
|
Chairpersons: Suzuki
A
(Sphingolipid Expression Laboratory, RIKEN Frontier Research System,
Tokorozawa, Japan),
Sasaki M
(Second Department of Surgery, Hirosaki University School of Medicine,
Hirosaki, Japan) |
 |
11:20-11:45
(25) |
II-1 MALIGNANT TRANSFORMATION-ASSOCIATED
CHANGES IN GENE EXPRESSION OF -1,4-GALACTOSYLTRANSFERASES
|
Furukawa K1,
Sato T1, Guo S1,
2, and Shirane K1, 3
1Department of Biosignal Research,
Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan, 2Department
of Pathology, Beijing Medical University, China, and 3
Nissin Flour Milling Co. Ltd., Tokyo, Japan
|
 |
11:45-12:00
(15) |
II-2 CHEMICAL STRUCTURE OF THE CARBOHYDRATE
MOIETY OF FUCOSE-RICH GLYCOPEPTIDES FROM HUMAN PANCREATIC JUICE |
Yoshihara S, Ichinohe K, Shibata S,
Toyoki Y, and Sasaki M
Second Department of Surgery, Hirosaki University School of Medicine,
Hirosaki, Japan
|
 |
| 12:00-13:00
(60) |
LUNCH |
 |
| [SESSION
III] |
MUCIN AS A BIOGENIC
MESSENGER |
| |
Chairpersons: Inazu
T
(The Noguchi Institute, Tokyo, Japan),
Munakata A
(First Department of Internal Medicine, Hirosaki University School
of Medicine, Hirosaki, Japan) |
13:00-13:25
(25) |
III-1 MUC1 AS A HUMAN TUMOR MARKER |
Imai K, Hayashi T, Suwa T, Makiguchi
Y, Itoh F, Hinoda Y, and Takahashi T
First Department of Internal Medicine, Sapporo Medical Universit
y School of Medicine, Sapporo, Japan
|
 |
13:25-13:40
(15) |
III-2 CHARACTERIZATION OF MUCIN IN WHOLE-GUT
LAVAGE FLUID OBTAINED FROM PATIENTS WITH INFLAMMATORY BOWEL DISEASE
|
Saitoh H, Tanaka H, Muramoto K, Kimura
S, Kubo K, Kas ai M, Yoshida Y, and Munakata A
First Department of Internal Medicine, Hirosaki University Schoo
l of Medicine, Hirosaki, Japan
|
 |
| 13:40-13:50
(10) |
COFFEE
BREAK |
 |
| [SESSION
IV] |
ROLES OF PROTEOGLYCANS
IN TISSUE ORGANIZATION |
| |
Chairpersons: Ishihara
M
(Division of Biomedical Engineering, Research Institute, National
Defense Medical College, Tokorozaw a, Japan).
Harata S
(Department of Orthopedics, Hirosaki University School of Medicine,
Hirosaki, Japan) |
13:50-14:30
(40) |
IV-1 THE RATIONALE FOR AND RESULTS OF
PRE-CLI NICAL TRIALS OF CHONDROITINASE ABC IN CHEMONUCLEOLYSIS |
Brown MD
Department of Orthopedics and Rehabilitation, University of Miami
School of Medicine, Miami, FL, USA
|
| |
|
14:30-14:45
(15) |
IV-2 CHANGES IN GLYCOSAMINOGLYCAN CHAINS
OF NUCLEUS PULPOSUS PROTEOGLYCAN OF BABOON VERTEBRAL DISCS WITH AGING |
Nakamura W, Yukawa M, Takeuchi
K, and Harata S
Department of Orthopedics, Hirosaki University School of Medicine,
H irosaki, Japan
|
 |
14:45-15:10
(25) |
IV-3 THE ROLE OF HYALURONAN IN THE TUMOR
FORMATION OF H-ras-TRANSFORMED RAT FIBROBLASTS |
Sawai T 1, 2,
Itano N 1, Hamaguchi M 3,
Miyaishi O 4, and Kimata K
1
1Institute for Molecular Science of Medicine,
Aichi Medical Univ ersity, 2Department
of Orthopedics Surgery, Jikei University School of Medicine, 3Department
of Molecular Pathogenesis, Nagoya University School of Medicine,
and 4Department of Basic Gerontology,
National Institute for Longevity Sciences, Japan
|
 |
| 15:10-16:00
(50) |
COFFEE
BREAK AND DISCUSSION OF POSTERS |
 |
| [SESSION
V] |
NEW DEVELOPMENTS
OF GLYCOSAMINOGLYCANS FOR CLINICAL APPLICATIONS |
|
Chairpersons: Kimata
K ,
(Institute for Molecular Science of Medicine, Aichi Medical University,
Aichi, Japan)
Saito Y
(Department of Obstetrics and Gynecology, Hirosaki University School
of Medicine, Hirosaki, Japan) |
 |
16:00-16:40
(40) |
V-1 USE OF GLYCOSAMINOGLYCANS FOR THE
TREATMENT OF INTERSTITIAL CYSTITIS - A STRATEGY TO IMPROVE EFFICACY |
Bhavanandan VP1,
Erickson DR2, Herb N1,
Sheykhnazari M1, and Ordille S2
1Department of Biochemistry and
Molecular Biology, 2Department of Surgery,
The Pennsylvania State University College of Medicine, Hershey,
PA, USA
|
 |
16:40-16:55
(15) |
V-2 ENZYMATIC RECONSTRUCTION OF GLYCOSAMINOGLYCAN
OLIGOSACCHARIDES |
Takagaki K, Kakizaki I, Iwafune
M, Ishido K and Endo M
Department of Biochemistry, Hirosaki University School of Medicine,
Hirosaki, Japan
|
 |
16:55-17:10
(15) |
V-3 4-METHYLUMBELLIFERONE INHIBITS HYALUYRONATE
SHYNTHESIS INCULTURED FIBROBLASTS FROM THE HUMAN UTERINE CERVIX |
Tanaka K, Higuchi T, Sato S,
and Saito Y
Department of Obstetrics and Gynecology, Hirosaki University School
of Medicine, Hirosaki, Japan
|
 |
17:10-17:20
(10) |
CLOSING
CLOSING REMARKS |
Harata S
Director, Hirosaki University Hospital, A Member of the Organizing
Committee, The 4th Meeting of Hirosaki International Forum of
Medical Science
|
 |
17:20-17:30
(10) |
BUSINESS MEETING |
Hirosaki International Forum of Medical
Science 2000
|
|